Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-01
1997-03-04
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142258, 514303, 514394, 514397, 514411, 544 38, 546118, 548252, 548254, 5483051, 5483114, 548444, A61K 3141, A61K 31415, C07D23354, C07D23504, C07D25704
Patent
active
056079559
ABSTRACT:
A tricyclic compound represented by the following formula (I): ##STR1## exhibits antagonism to angiotensin II receptors.
REFERENCES:
patent: 4122186 (1978-10-01), Lafon
patent: 5128356 (1992-07-01), Naka et al.
patent: 5302596 (1994-04-01), Oshima
J. Med. Chem., vol. 34, No. 9 2919-22. (1991).
Ishikawa Tomoko
Kanai Fumihiko
Kumazawa Toshiaki
Obase Hiroyuki
Ohno Tetsuji
Huang Evelyn
Ivy C. Warren
Kyowa Hakko Kogyo Co. Ltd.
LandOfFree
Tricyclic compounds on angiotensin II receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic compounds on angiotensin II receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds on angiotensin II receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2146224